What’s on the minds of the world’s top medtech executives? … READ MORE >
FDA
5 things to know in life sciences: Week of October 14, 2024
Competition continues to increase in the obesity treatment space. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of August 26, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of July 8, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of May 27, 2024
From the importance of decentralized clinical trials to growing weight loss drug revenues, here’s what’s happening in life sciences. … READ MORE >
5 things to know in life sciences: Week of May 20, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of May 13, 2024
Five key FDA decisions to watch for and more in this week’s life sciences recap. … READ MORE >
5 things to know in life sciences: Week of May 6, 2024
From pharma’s interest in influencer marketing to a possible summer surge in biotech IPOs, here’s the latest in life sciences. … READ MORE >
5 things to know in life sciences: Week of April 29, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
Key takeaways for life sciences on laboratory developed tests final rule
The FDA released a final rule regarding laboratory developed tests. There are key considerations on enforcement discretion and phaseout schedule. … READ MORE >